Pier Capital’s AtriCure ATRC Stock Holding History

Pier Capital’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-266,068	Closed	-$4.48M	–	117
2016 Q1	$4.48M	Sell	266,068 -32,798	-11%	-$577K	0.86%	76
2015 Q4	$6.71M	Buy	298,866 +2,178	+0.7%	+$44.9K	1.16%	24
2015 Q3	$6.5M	Buy	+296,688	New	+$7.41M	1.06%	34

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Pier Capital's ATRC Position: Q2 2016 in Review

Pier Capital sold out of AtriCure (ATRC) in Q2 2016, closing a stake of 266,068 shares — an estimated $4.48M sold.

Pier Capital first reported a position in ATRC in Q3 2015 and held it in 3 quarters. The position peaked at $6.71M in Q4 2015. 102 funds tracked by Wall St. Rank hold ATRC as of Q2 2016.

Pier Capital reported no remaining AtriCure position as of Q2 2016 after selling out during the quarter.
Pier Capital sold 266,068 AtriCure shares in Q2 2016, an estimated $4.48M.
Pier Capital first reported a position in AtriCure in Q3 2015 and held it in 3 quarters.
Pier Capital's AtriCure position peaked at $6.71M in Q4 2015.
102 funds tracked by Wall St. Rank held AtriCure as of Q2 2016.

Based on Pier Capital's 13F filing for Q2 2016, filed 15 Aug 2016.